{"created":"2023-05-15T09:06:47.708331+00:00","id":13780,"links":{},"metadata":{"_buckets":{"deposit":"eb8d0bba-3693-44cb-a5b6-45f8f2d026eb"},"_deposit":{"created_by":14,"id":"13780","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"13780"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00013780","sets":["1875:1978:1996"]},"author_link":["21696","21697","21698"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"188","bibliographicPageStart":"185","bibliographicVolumeNumber":"74","bibliographic_titles":[{"bibliographic_title":"市立札幌病院医誌"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"2013年3月?2014年9月にセツキシマブ(商品名 : アービタックス) を併用した根治的分子標的薬併用放射線治療を施行した頭頸部癌10例について、一次効果と有害事象について検討した。一次効果はCRが9 例、PRが1 例で良好な成績であった。一方で皮膚炎・粘膜炎・ざ瘡様皮疹の有害事象を認め、皮膚炎はGrade3 が60.0%、粘膜炎はGrade3 が70.0% と高度な有害事象の割合は高いものであった。有害事象の増悪時には栄養介入やセツキシマブ投与中止など、適宜介入が必要と考える。","subitem_description_type":"Abstract"}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"市立札幌病院"}]},"item_2_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"土屋, 高旭"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"池田, 光"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"高田, 優"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-07-21"}],"displaytype":"detail","filename":"l4256742185.pdf","filesize":[{"value":"7.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"l4256742185.pdf","url":"https://sapmed.repo.nii.ac.jp/record/13780/files/l4256742185.pdf"},"version_id":"756c5a16-9257-467d-9d6b-1b85a58e9efc"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"放射線治療","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"頭頸部癌","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"セツキシマブ","subitem_subject_language":"ja","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"当院における頭頸部癌に対するセツキシマブ併用放射線治療","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"当院における頭頸部癌に対するセツキシマブ併用放射線治療","subitem_title_language":"ja"}]},"item_type_id":"2","owner":"14","path":["1996"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-05-12"},"publish_date":"2017-05-12","publish_status":"0","recid":"13780","relation_version_is_last":true,"title":["当院における頭頸部癌に対するセツキシマブ併用放射線治療"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T04:29:50.090701+00:00"}